Upper Respiratory Disease Associated with a Novel Mycoplasma Isolate From Eastern Box Turtles (Terrapene carolina carolina)
American Association of Zoo Veterinarians Conference 2004
Sanford H. Feldman1, DVM, PhD, DACLAM; Jeffrey Wimsatt2, DVM, PhD; Rachel E. Marchang3, DVM; April J. Johnson4, DVM; William Brown5, BS; Joseph Mitchell6, PhD; Jonathan Sleeman7, BA, VetMB, DACZM, MRCVS
1Center for Comparative Medicine, Department of Medicine, University of Virginia, Charlottesville, VA, USA; 2Department of Biology, University of Virginia, Charlottesville, VA, USA; 3Institut für Umwelt- und Tierhygiene, Universität Hohenheim, Stuttgart, Germany; 4Department of Small Animal Clinical Sciences, Veterinary Medical Teaching Hospital, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA; 6Blue Ridge Biological, Stanardsville, VA, USA; 6Deparment of Biology, University of Richmond, Richmond, VA, USA; 7Wildlife Center of Virginia, Waynesboro, VA, USA

Abstract

A new upper respiratory disease syndrome, similar to upper respiratory tract disease (URTD) affecting American tortoises,4,5 was identified in wild Eastern box turtles (Terrapene carolina carolina) from Virginia. Coincident with this discovery, turtles submitted to both the University of Virginia and the Wildlife Center of Virginia presented with tympanic bulging, oral lesions, swollen eyelids or mucopurulent nasal discharge typical of upper respiratory disease, commonly attributed to vitamin A deficiency1 and organochlorine exposure6,10. The present preliminary study was undertaken to determine the geographic distribution of the URTD-like disease in Virginia, to assess its prevalence in animals exhibiting the latter somewhat similar upper respiratory disease syndrome (URS), and to characterize the phylogenetic relationship of this Mycoplasma isolate to other pathogenic members of the genus.2

Results

Clinically, affected animals exhibited varied signs including unilateral to bilateral serous to mucopurulent nasal discharge, epiphora, and conjunctival injection and edema. All animals were collected from May through July, in 2001–3. Generic and agent-specific PCR detected Mycoplasma-positive nasal swabs from seven of 24 animals sampled, representing six of eleven Virginia counties where animals originated. Three specific Mycoplasma PCR-positive animals had aural bulging or oral lesions typical of URS, while four did not. A single animal without any upper respiratory signs that underwent a saline nasal flush was PCR positive, while 13 others without any upper respiratory signs, likewise flushed and screened were PCR negative. Sequence analysis based on the 16S ribosomal region from three clinical cases and a presumed carrier not exhibiting signs, representing isolates from four different counties, revealed a single unique agent. The new isolate was distinct from M. agassizii, but closely (98% 16S sequence agreement) related. Nasal swab samples from all the animals were negative for chelonian herpesviruses11,12 and invertebrate7 and vertebrate (including FV3)8,9 iridoviruses by PCR.

Discussion

These preliminary findings suggest the emergence of a new URTD-like syndrome in Eastern box turtles from Virginia. Clinically, this disease was indistinguishable from M. agassizii-induced disease in tortoises, except for a differing species predilection.4,5 Although preliminary, no relationship was noted between Mycoplasma PCR positive tests, and URS signs common to wild turtles from this region. Similar to the description of tortoise URTD,3 preliminary observations suggest that animals may harbor the agent, but exhibit only intermittent clinical signs, and clinical signs appeared to increase the likelihood of disease detection by nasal swab/conjunctival PCR testing as in URTD (Wimsatt, unpublished data). To our knowledge, this is the first report of a Mycoplasma recovered from multiple clinically ill wild box turtles from the mid-Atlantic region of the US, a purportedly M. agassizii-free area. Further work is required to confirm that this unique Mycoplasma isolate is the causative agent of the observed disease syndrome, to map and assess the agent’s distribution and impact on wild turtle populations, to identify cofactors facilitating disease progression, and to better classify the organism biochemically and taxonomically.

Acknowledgments

We would like to thank Elliott Jacobson for helpful suggestions, and Joe Mitchell and Jean Marie Richards for their valuable contributions. Samples were collected under permits from the Virginia Department of Game and Inland Fisheries (Scientific Collection Permit number 022992), and federal permit FRSP-2003-SCI-0002 from the National Park Service.

Literature Cited

1.  Boyer, T. 1996. Hypovitaminosis A and hypervitaminosis A. In: D.R. Mader (Ed) Reptile Medicine and Surgery. W.B. Saunders, Philidelphia, PA. Pp 382–385.

2.  Brown, D.R. 2002. Mycoplasmosis and immunity of fish and reptiles. Front. Biosci. 7:d1338–1346.

3.  Brown, M.B., K.H. Berry, I.M. Schumacher, K.A. Nagy, M.M. Christopher and P.A. Klein. 1999. Seroepidemiology of upper respiratory tract disease in the desert tortoise in the western Mojave Desert of California. J. Wildl. Dis. 35:716–727.

4.  Brown, M.B., D.R. Brown, P.A. Klein, G.S. Mclaughlin, I.M. Schumacher, E.R. Jacobson, H.P. Adams and J.G. Tully. 2001. Mycoplasma agassizii sp. nov., isolated from the upper respiratory tract of the desert tortoise (Gopherus agassizii) and the gopher tortoise (Gopherus polyphemus). Int. J. Syst. Evol. Microbiol. 51:413–418.

5.  Brown, M.B., G.S. Mclaughlin, P.A. Klein, B.C. Crenshaw, I.M. Schumacher, D.R. Brown and E.R. Jacobson. 1999. Upper respiratory tract disease in the gopher tortoise is caused by Mycoplasma agassizii. J. Clin. Microbiol. 37:2262–2269.

6.  Holladay, S., J. Wolf, S. Smith and D. J. J. Robertson. 2001. Aural abscesses in wild-caught box turtles (Terrapene carolina): possible role of organochlorine-induced hypovitaminosis A. Ecotoxicol. Environ. Res. Section B 48, 99–106.

7.  Just, F., S. Essbauer, W. Ahne and S. Blahak. 2001. Occurrence of an invertebrate iridescent-like virus (Iridoviridae) in reptiles. J. Vet. Med. B. 48:685–694.

8.  Mao, J., R. Hedrick and V. Chinchar. 1997. Molecular characterization, sequence analysis and taxonomic position of newly isolated fish iridoviruses. Virology. 229:212–220.

9.  Marschang, R., P. Becher, H. Posthaus, P. Wild, H.-J. Thiel, U. Müller-Doblies, E. Kaleta and L. Bacciarini. 1999. Isolation and characterization of an iridovirus from Hermann’s tortoises (Testudo hermanni). Arch. Virol. 144:1909–1922.

10.  Tangredi, B. and R. Evans. 1997. Organochlorine pesticides associated with ocular, nasal or otic infection in the Eastern box turtle (Terrapene carolina carolina). J. Zoo Wildl. Med. 28:97–100.

11.  Une, Y., M. Murakami, K. Uemura, H. Fujitani, T. Ishibashi and Y. Nomura. 2000. Polymerase chain reaction (PCR) for the detection of herpesvirus in tortoises. J. Vet. Med. Sci. 62:905–907.

12.  Van Devanter, D., P. Warrener, L. Bennett, E. Schultz, S. Coulter, R. Garber and T. Rose. 1996. Detection and analysis of diverse herpesviral species by consensus primer PCR. J Clin Microbiol. 34:1666–1671.

 

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Jeffrey Wimsatt, DVM, PhD
Department of Biology and Center for Comparative Medicine
University of Virginia
Charlottesville, VA, USA


MAIN : 2004 : Turtle Upper Respiratory Disease & a Novel Mycoplasma
Powered By VIN
SAID=27